APA (7th ed.) Citation

Wang, Z., Chen, J., Song, J., Kong, L., Wang, X., Xu, T., . . . Dou, Y. (2023). Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension. Diabetes, metabolic syndrome and obesity, 16, 1133-1147. https://doi.org/10.2147/DMSO.S410682

Chicago Style (17th ed.) Citation

Wang, Ziran, Jintu Chen, Jingjing Song, Lingjun Kong, Xuanzhi Wang, Tengda Xu, Songbai Lin, and Yaling Dou. "Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension." Diabetes, Metabolic Syndrome and Obesity 16 (2023): 1133-1147. https://doi.org/10.2147/DMSO.S410682.

MLA (9th ed.) Citation

Wang, Ziran, et al. "Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension." Diabetes, Metabolic Syndrome and Obesity, vol. 16, 2023, pp. 1133-1147, https://doi.org/10.2147/DMSO.S410682.